1. Home
  2. VNT vs MMED Comparison

VNT vs MMED Comparison

Compare VNT & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vontier Corporation

VNT

Vontier Corporation

N/A

Current Price

$31.84

Market Cap

4.3B

Sector

Industrials

ML Signal

N/A

MMED

MiniMed Group Inc. Common Stock

N/A

Current Price

$17.67

Market Cap

4.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VNT
MMED
Founded
2019
1983
Country
United States
United States
Employees
N/A
2800
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.3B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
VNT
MMED
Price
$31.84
$17.67
Analyst Decision
Buy
Strong Buy
Analyst Count
9
10
Target Price
$46.89
$22.56
AVG Volume (30 Days)
1.4M
1.0M
Earning Date
05-07-2026
06-03-2026
Dividend Yield
0.29%
N/A
EPS Growth
0.36
N/A
EPS
0.66
N/A
Revenue
$3,075,600,000.00
N/A
Revenue This Year
$2.39
$15.99
Revenue Next Year
$4.19
$10.00
P/E Ratio
$46.64
N/A
Revenue Growth
3.24
N/A
52 Week Low
$27.25
$10.65
52 Week High
$48.20
$17.86

Technical Indicators

Market Signals
Indicator
VNT
MMED
Relative Strength Index (RSI) 66.22 68.77
Support Level $27.72 $14.70
Resistance Level $37.95 N/A
Average True Range (ATR) 0.74 0.92
MACD 0.23 0.09
Stochastic Oscillator 99.13 95.75

Price Performance

Historical Comparison
VNT
MMED

About VNT Vontier Corporation

Vontier, spun off from Fortive in 2020, is an industrial technology company with a portfolio of transportation and mobility solutions. The company offers a wide array of products and services, including fueling equipment, sensors, point-of-sale and payment systems, telematics, and equipment used by vehicle mechanics and technicians. Vontier generated approximately $3.1 billion in sales in 2025.

About MMED MiniMed Group Inc. Common Stock

Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.

Share on Social Networks: